Metformin 1500 mg daily

DRUG4 trials

Sponsors

Novartis Pharmaceuticals, Meir Medical Center, Helsinki University Central Hospital, PAEC general hospital

Conditions

Diabetes Mellitus, Type 2Diabetes Type 2PCOS (Polycystic Ovary Syndrome)Polycystic Ovary Syndrome (PCOS)

Phase 3

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

CompletedNCT00383578

Novartis PharmaceuticalsDiabetes Mellitus, Type 2

Start: 2006-09-30Updated: 2020-12-17

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Meir Medical CenterDiabetes Type 2

Start: 2008-06-30End: 2012-12-31Target: 1000Updated: 2012-03-19

Optimizing Metformin Use in Polycystic Ovary Syndrome

Not yet recruitingNCT07120815

Helsinki University Central HospitalPolycystic Ovary Syndrome (PCOS)

Start: 2025-09-01End: 2028-12-31Target: 184Updated: 2025-08-13

Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

CompletedNCT07323589

PAEC general hospitalPCOS (Polycystic Ovary Syndrome)

Start: 2025-01-01End: 2025-10-25Updated: 2026-01-07

Related Papers

Optimising metformin use in polycystic ovary syndrome (MET-PCOS): study protocol for a double-blind randomised controlled trial.

2026-03-12

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01